Approved for both: It is approved for metastatic and early breast cancer that are her2 positive. Also approved for her2 positive stomach/esophageal cancer. Herceptin (trastuzumab) was approved for early breast cancer in november 2006. The standard therapy is 1 year. Hope this helps.
Answered 6/25/2014
5.5k views
It is recommended fo: Herceptin (trastuzumab) is recommended and it is commonly used for both early stages of breast cancer(adjuvant therapy) as well as for metasttic breast cancer of the her2 type of breast cancer only.
Answered 6/25/2014
5.2k views
Used in both setting: For your information, Herceptin (trastuzumab) is used and indicated for both settings- for early breast cancer- at least is given for 1 year - as well as for advanced metastatic breast cancer.
Answered 6/25/2014
5.2k views
4 doctors weighed in across 2 answers
7 doctors weighed in across 3 answers
4 doctors weighed in across 2 answers
4 doctors weighed in across 3 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question